Condition
Corneal Perforation
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
80% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed4
Terminated1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06539663Phase 2CompletedPrimary
The Role of OmniLenz® in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU Patients
NCT06422897CompletedPrimary
Role of AS-OCT in Assessment of Corneal Perforation
NCT03500796Not ApplicableCompletedPrimary
Combined Amniotic Membrane and Platelet Rich Plasma Clot for Management of Central Corneal Perforation
NCT04820010Completed
Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3
NCT02116062Not ApplicableTerminated
Robotic Surgery of the Ocular Surface
Showing all 5 trials